Tag: genomics
-
Engineered Chickpea with Increased Protein Unveiled
An agricultural biotechnology company is introducing genetically altered chickpeas with much higher protein content than today’s varieties.
-
Saliva Test IDs Early Oral Cancer Signature
An analysis is shown to identify characteristic patterns found in microbial communities in saliva indicating early stages of oral and throat cancer.
-
Preclinical Test Advances Synthetic Bio ALS Treatment
A candidate treatment for amyotrophic lateral sclerosis or ALS made with synthetic genetic material is shown to improve motor function and survival in lab mice.
-
Engineered Virus Delivers Brain-Targeted Gene Therapy
Neuroscience researchers designed a process for delivering gene therapies through the blood stream, but targeting only brain cells of lab animals.
-
Messenger RNA Developer ETF Launches
A new exchange traded fund or ETF is underway for individuals to invest in companies developing vaccines or therapies with messenger RNA.
-
Oxford, GSK Partner on New Tech for Neuro Diseases
GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders.
-
Samsung, Biotech Partner on mRNA Vaccine Production
A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA.
-
Novo Nordisk Buys RNA Biotech in $3.3B Deal
Global drug maker Novo Nordisk is acquiring biotechnology company Dicerna Pharmaceuticals Inc. in an all-cash deal valued at $3.3 billion.
-
Synthetic Bio Milk Company Gains $13M in Seed Funds
A start-up enterprise creating milk and dairy products with proteins derived from engineered microorganisms is raising $13 million in seed funds.
-
New Company to Develop Synthetic Antibody Therapies
A new business is underway to develop and commercialize treatments for Covid-19 and other diseases based on synthetic antibody proteins.